PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
July 27, 2015New England Journal of Medicine1,100 citationsOpen Access

Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease

View Full Paper
SHSri Rezeki HadinegoroJAJosé Luis Arredondo-Garcı́aMexican Social Security InstituteMCMaria Rosario Capeding

Key Points

Key points are not available for this paper at this time.

Abstract

Although the unexplained higher incidence of hospitalization for dengue in year 3 among children younger than 9 years of age needs to be carefully monitored during long-term follow-up, the risk among children 2 to 16 years of age was lower in the vaccine group than in the control group. (Funded by Sanofi Pasteur; ClinicalTrials.gov numbers, NCT00842530, NCT01983553, NCT01373281, and NCT01374516.).

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Hadinegoro et al. (2015) studied this question.

synapsesocial.com/papers/69d759a8f182769aa8b8a815https://doi.org/10.1056/nejmoa1506223
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Age-related changes in microvascular permeability: a significant factor in the susceptibility of children to shock?2000 · 129 citations
  2. 2Age‐Related Increase in the Frequency of CD4+T Cells That Produce Interferon‐γ in Response to Staphylococcal Enterotoxin B during Childhood2009 · 30 citations
  3. 3The Epidemiology of Dengue in the Americas Over the Last Three Decades: A Worrisome Reality2010 · 550 citations
  4. 4On the risk of severe dengue during secondary infection: A systematic review coupled with mathematical modeling2014 · 44 citations
  5. 5Epidemiological Factors Associated with Dengue Shock Syndrome and Mortality in Hospitalized Dengue Patients in Ho Chi Minh City, Vietnam2011 · 255 citations